Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms.

已完结 100 由妹妹发布于 2026/7/25 11:38:56

DOI:10.1200/OP-26-00074
作者：Jennifer W Carlisle, Katherine O'Reilly, Xiyuan Angel Ji, Jeffrey M Switchenko, Conor E Steuer, Fatemeh Ardeshir-Larijani, Suresh S Ramalingam, Ticiana Leal
文献类型：期刊论文
补充材料：只需要正文

American Society of Clinical Oncology (ASCO)

Abstract：Purpose: Tarlatamab-dlle, a bispecific T-cell engager targeting delta-like ligand 3 (DLL3) for relapsed small cell lung cancer (SCLC), requires hospitalization and observation for 24 hours a

应助信息

15小时前

jie81

03c491d087db11f1a9b834735aa3bc31.pdf 已采纳

15小时前

Book学术机器人

2026/7/25 11:38:56 未找到该文献，机器人已退出，请等待人工下载

2026/7/25 11:38:56 Book学术AI机器人收到请求，开始寻找文献

2026/7/25 11:38:56 已向机器人发送请求

15小时前

妹妹发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierExperimental investigations on enhancing flow boiling heat transfer in straight and wavy copper foam fin microchannels